<DOC>
	<DOCNO>NCT00148551</DOCNO>
	<brief_summary>A 24 - month Study look change visual acuity patient receive PDT therapy conjunction intravitreal triamcinolone .</brief_summary>
	<brief_title>Triamcinolone Acetonide Adjunctive VPDT ARMD .</brief_title>
	<detailed_description>This study evaluate effect Triamcinolone Acetonide conjunction photodynamic therapy treatment sub-foveal choroidal neovascular membrane secondary age-related macular degeneration .</detailed_description>
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>Individuals predominantly classic , subfoveal CNV secondary AMD . No previous PDT Treatment study eye . CNV condition , AMD . Other disease could responsible decreased vision .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>AMD</keyword>
	<keyword>Triamcinolone</keyword>
	<keyword>Macular Degeneration</keyword>
</DOC>